In our second IP Strategy Report, we discuss the optimal allocation, ownership, and exploitation of intangible assets by parties to the collaboration.
Join us for a Roundtable Discussion of the Health Impact Fund on May 12, 2020, Noon-1:30 pm ET.
The United States Supreme Court heard oral argument by teleconference on Monday, May 4, a first in the court’s 230-year history.
With worldwide supplies of essential medical equipment running low, some companies are capitalizing on the COVID-19 pandemic by charging higher than normal prices, sometimes called “price gouging.”
On April 7th, the Federal Court released its first ruling on the interpretation of the Certificate of Supplementary Protection (CSP) regime.
The rapid spread of COVID-19 has prompted generous responses from public and private actors that would be unthinkable in ordinary times.
On March 25, Canada’s federal government passed Bill C-13 in response to the COVID-19 pandemic.
A well-drafted collaboration agreement is critical in cementing the rights and obligations of each party to the collaborative engagement.
As a preventative measure, the physical Gilbert’s LLP office is closing for the time being.
We invite you to join the Intellectual Property Institute of Canada for a 1.5 hour webinar featuring Gilbert’s LLP’s Zarya Cynader.
On December 13, 2018, Bill C-86, an omnibus budget implementation bill, received Royal Assent. The bill makes several important changes to Canada’s intellectual property laws under the Patent Act and Trademarks Act.
Worried about being resurrected as a hologram after death? Lawrence Veregin shares some thoughts.
At Gilbert's LLP, we do things a little differently. Learn more about our student recruiment program.